Benjamin Jen

Director/Board Member presso JIANGSU CNANO TECHNOLOGY CO., LTD.

58 anni

Electronic Technology

Finance

Producer Manufacturing

Profilo

Benjamin C.
M.
Jen is the founder of GRC Sinogreen Investment Advisor (Beijing) Co. Ltd.
founded in 2005, where he holds the title of Managing Partner.
Currently, he holds the position of Director at Jiangsu Cnano Technology Co., Ltd.
since 2015, Director at Applied BioCode Corp.
since 2016, and Director at Applied BioCode, Inc. He previously held the position of Director at Applied Optoelectronics, Inc. Mr. Jen's education history includes an undergraduate degree from the University of Missouri and an MBA from the Massachusetts Institute of Technology.

Posizioni attive di Benjamin Jen

Società	Posizione	Inizio
JIANGSU CNANO TECHNOLOGY CO., LTD.	Director/Board Member	01/03/2015
APPLIED BIOCODE CORPORATION	Director/Board Member	29/09/2016
GRC Sinogreen Investment Advisor (Beijing) Co. Ltd. GRC Sinogreen Investment Advisor (Beijing) Co. Ltd. Investment ManagersFinance GRC SinoGreen Investment Advisor (Beijing) Co. Ltd. (GRC SinoGreen Fund) is an independent private equity/venture capital firm founded in 2005 by Yuan-Chi Chao and Benjamin Jen. GRC SinoGreen Fund is headquartered in Beijing and has offices in Taipei and Shenzhen.	Founder	01/01/2005
Applied BioCode, Inc. Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The private company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022.	Director/Board Member	-

Tutte le posizioni attive di Benjamin Jen

Precedenti posizioni note di Benjamin Jen

Società	Posizione	Fine
APPLIED OPTOELECTRONICS, INC.	Director/Board Member	27/02/2013

Vedi nel dettaglio l'esperienza di Benjamin Jen

Formazione di Benjamin Jen

University of Missouri	Undergraduate Degree
Massachusetts Institute of Technology	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Benjamin Jen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
APPLIED OPTOELECTRONICS, INC.	Electronic Technology
JIANGSU CNANO TECHNOLOGY CO., LTD.	Producer Manufacturing
APPLIED BIOCODE CORPORATION	Health Technology

Aziende private	2
GRC Sinogreen Investment Advisor (Beijing) Co. Ltd. GRC Sinogreen Investment Advisor (Beijing) Co. Ltd. Investment ManagersFinance GRC SinoGreen Investment Advisor (Beijing) Co. Ltd. (GRC SinoGreen Fund) is an independent private equity/venture capital firm founded in 2005 by Yuan-Chi Chao and Benjamin Jen. GRC SinoGreen Fund is headquartered in Beijing and has offices in Taipei and Shenzhen.	Finance
Applied BioCode, Inc. Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The private company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022.	Electronic Technology